• Activity INFORMATION

  Overview

  Glucagon like peptide 1 agonists (GLP-1) are used in treating type 2 diabetes and for the achievement of weight loss. Obesity has been associated with an increased risk of developing type 2 diabetes. Furthermore, American Diabetes Association (ADA) estimates that more than 90% of patients who are overweight or obese are aslo diagnosed with type 2 diabetes. The recently updated ADA 2022 guidelines recommend choosing first line medications based on patient’s concurrent diseases. Therefore, in this session we will review the difference between GLP-1 agonists and their role in type 2 diabetes and obesity. Additionally, after the webinar pharmacy technicians will be able to recognize the GLP-1 agonist injection techniques, their storage and list some of the common available patient assistance programs.

  Handouts

  • Slide Document :   22159H01_2pp.pdf Download

  • Slide Document :   22159H01_6pp.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacy Technician

  Identify appropriate GLP-1 agonist injection techniques

  List important clinical considerations for GLP-1 agonists

  Compare and contrast the differences between GLP-1 agonists

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-970888

  Universal Activity Number

  Pharmacy Technician 0798-0000-22-259-H01-T
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Kevin  Hope, RPh Senior Director of Continuing Education, PharmCon

  Farsheed  Umari, PharmD MedWiseRx

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).